Chi‐Chang Chen

1.3k total citations
92 papers, 883 citations indexed

About

Chi‐Chang Chen is a scholar working on Plant Science, Molecular Biology and Hematology. According to data from OpenAlex, Chi‐Chang Chen has authored 92 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Plant Science, 18 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Chi‐Chang Chen's work include Multiple Myeloma Research and Treatments (11 papers), Plant tissue culture and regeneration (9 papers) and Chromosomal and Genetic Variations (8 papers). Chi‐Chang Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Plant tissue culture and regeneration (9 papers) and Chromosomal and Genetic Variations (8 papers). Chi‐Chang Chen collaborates with scholars based in United States, United Kingdom and Taiwan. Chi‐Chang Chen's co-authors include Pryce B. Gibson, Catherine B. McGuiness, William F. Grant, Rolin L. Wade, Melissa M. Kemp, Michel Weïwer, Robert J. Linhardt, Wen‐Huei Chen, Chiung‐Chyi Shen and Philip O. Buck and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Chi‐Chang Chen

86 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Chang Chen United States 19 351 309 109 83 81 92 883
Alan Reynolds United Kingdom 18 244 0.7× 355 1.1× 124 1.1× 41 0.5× 64 0.8× 37 1.3k
M A Martin United States 14 298 0.8× 449 1.5× 341 3.1× 34 0.4× 110 1.4× 24 1.4k
Tomaž Vaupotič Slovenia 12 125 0.4× 571 1.8× 59 0.5× 37 0.4× 49 0.6× 19 1.1k
Thomas Jacob United States 15 99 0.3× 194 0.6× 243 2.2× 16 0.2× 17 0.2× 29 776
Hiroshi Terunuma Japan 18 47 0.1× 174 0.6× 338 3.1× 12 0.1× 298 3.7× 58 1.4k
Panpan Lu China 14 244 0.7× 334 1.1× 141 1.3× 6 0.1× 141 1.7× 25 983
Ming Yue China 19 36 0.1× 187 0.6× 260 2.4× 37 0.4× 69 0.9× 107 1.0k
Hermenio Lima Brazil 18 70 0.2× 126 0.4× 308 2.8× 14 0.2× 37 0.5× 61 1.1k
Lisa Macera Italy 19 156 0.4× 66 0.2× 205 1.9× 11 0.1× 140 1.7× 42 930
Rita Casetti Italy 22 61 0.2× 137 0.4× 396 3.6× 16 0.2× 223 2.8× 56 1.7k

Countries citing papers authored by Chi‐Chang Chen

Since Specialization
Citations

This map shows the geographic impact of Chi‐Chang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chang Chen more than expected).

Fields of papers citing papers by Chi‐Chang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Chang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chang Chen. The network helps show where Chi‐Chang Chen may publish in the future.

Co-authorship network of co-authors of Chi‐Chang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Chang Chen. A scholar is included among the top collaborators of Chi‐Chang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Chang Chen. Chi‐Chang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boytsov, Natalie, et al.. (2025). Impact of social determinants of health on treatment patterns and outcomes in multiple myeloma. Future Oncology. 21(13). 1663–1673.
3.
Hersh, Carrie M., et al.. (2024). Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 91. 105888–105888. 2 indexed citations
4.
Singal, Amit G., Xiaozhou Fan, Zdravko P. Vassilev, et al.. (2023). Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States. Cancers. 15(23). 5532–5532. 8 indexed citations
5.
Chen, Chi‐Chang, et al.. (2023). Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults. Current Medical Research and Opinion. 40(1). 125–140. 6 indexed citations
6.
Desai, Payal, Chi‐Chang Chen, Catherine B. McGuiness, et al.. (2023). Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy. Current Medical Research and Opinion. 39(4). 555–565. 1 indexed citations
7.
8.
Eichenfield, Lawrence F., April W. Armstrong, Emma Guttman‐Yassky, et al.. (2022). Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset. Dermatology and Therapy. 12(6). 1337–1350. 6 indexed citations
9.
10.
Zhu, Julia, et al.. (2019). Outcome evaluation of a subcutaneous immunoglobulin clinical management program. Journal of Research in Pharmacy Practice. 8(2). 52–52. 2 indexed citations
11.
Baum, Seth J., Chi‐Chang Chen, Pallavi Rane, et al.. (2018). CARDIOVASCULAR RISK IN PATIENTS DENIED ACCESS TO PCSK9I THERAPY. Journal of the American College of Cardiology. 71(11). A1760–A1760. 6 indexed citations
12.
13.
Chen, Chi‐Chang, Catherine B. McGuiness, Girishanthy Krishnarajah, et al.. (2016). Estimated incidence of pertussis in people aged <50 years in the United States. Human Vaccines & Immunotherapeutics. 12(10). 2536–2545. 14 indexed citations
14.
Ben‐Joseph, Rami, et al.. (2014). Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans. Journal of Medical Economics. 17(10). 708–718. 4 indexed citations
15.
Hess, Gregory P., Jerrold Hill, Monika Raut, et al.. (2010). Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis. Advances in Therapy. 27(10). 743–755. 19 indexed citations
16.
Weïwer, Michel, Chi‐Chang Chen, Melissa M. Kemp, & Robert J. Linhardt. (2009). Synthesis and Biological Evaluation of Non‐Hydrolyzable 1,2,3‐Triazole‐Linked Sialic Acid Derivatives as Neuraminidase Inhibitors. European Journal of Organic Chemistry. 2009(16). 2611–2620. 45 indexed citations
17.
Lin, Chih‐Chung, et al.. (2005). Genome organization and relationships of Phalaenopsis orchids inferred from genomic in situ hybridization. Zhōngyāng yánjiūyuàn zhíwùxué huikān/Zhōngyāng yánjiūyuàn zhíwùxué huikān. 11 indexed citations
18.
Kao, Ting‐Hsien, et al.. (2005). “Primary” Benign Retroperitoneal and Intraspinal Dumbbell-Shaped Cystic Teratoma. Spine. 30(15). E439–E443. 10 indexed citations
19.
20.
Chen, Chi‐Chang, et al.. (1982). Genetic analysis of anther-derived plants of rice. Journal of Heredity. 73(1). 49–52. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Reynolds Breakdown of academic impact, for papers by M A Martin Breakdown of academic impact, for papers by Tomaž Vaupotič Breakdown of academic impact, for papers by Thomas Jacob Breakdown of academic impact, for papers by Hiroshi Terunuma Breakdown of academic impact, for papers by Panpan Lu Breakdown of academic impact, for papers by Ming Yue Breakdown of academic impact, for papers by Hermenio Lima Breakdown of academic impact, for papers by Lisa Macera Breakdown of academic impact, for papers by Rita Casetti
Rankless by CCL
2026